EDUCATION & ACADEMIC TITLES

ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI  DEPARTMENT OF NUTRITION AND DIETETICS

April 2013

Graduated Dietitian - Nutritionist

- NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS

2018

Diabetes Mellitus

2013 - 2014

Medical Psychology

Psychogenic Eating Disorders (Anorexia Nervosa and Bulimia Nervosa)

- KORELKO

May 2020

Clinical Pediatrics

PROFESSIONAL EXPERIENCE

• METROPOLITAN HOSPITAL
  - Head Dietitian of Metropolitan Hospital Cardiometabolic-Diabetes Center
  March 2020- Today
  - Dietitian-Nutritionist in Outpatient Department
  May 2017 - Today
• THERAPIS GENERAL HOSPITAL
  Head of the Dietetic Department
  January 2022 - Today
• DIETARY OFFICE “Epicurean Diet” Kolonaki, Athens
  Owner and Head Dietitian - Nutritionist
  February 2015 - Today
• WEST ATHENS GENERAL CLINIC
  Head of the Dietetic Department
  February 2017 - February 2022
• "ATHENA" GENERAL CLINIC
  Head of Nutrition Department
  March 2014 - October 2016
• "GALINOS" GENERAL CLINIC
  Head of Nutrition Department
  June 2014 - October 2016
• KYANOYS STAVROS
  Dietician - Nutritionist (Practical Exercise)
  May 2011 - October 2012
• "PAPAGEORGIOU" GENERAL HOSPITAL OF THESSALONIKI
  Clinical Nutrition Internship
  September 2010 - January 2011

MEMBERSHIP IN SOCIETIES & EDITORIAL BOARDS

Member of the Hellenic Association of Dietitians

CONTACT INFO

+30 210 4809427

EDUCATION & ACADEMIC TITLES

May 2000: Degree in Medicine by the Medical School of Justus-Liebig University in Giessen, Germany

March 2010: Board certification in Hematology

December 2014: Dissertation by the Medical School of National and Capodistrian University of Athens, Greece: Study of the prognostic impact of serum free light chain ratio in patients with multiple myeloma. Investigation of biological mechanisms regulating secretion of free light chains by neoplasmatic plasma cells

PROFESSIONAL EXPERIENCE

• 7/2000 – 1/2002 Residency in Internal Medicine Klinikum Offenbach, Germany
• 3/2004 – 3/2005 Obligatory Service as General Practicioner
• 5/2005 – 11/2005 Residency in Internal Medicine in the Hospital for special diseases in Thessaloniki, Greece
• 11/2005 – 11/2009 Fellowship in Hematology in “Metaxa” hospital in Piraeus
• 7/2010 – 2/2011 Hematologist, Tzaneio Hospital, Piraeus, Greece
• 2/2011 – 12/2014 Hematologist, Florina General hospital, Greece
• 1/2015 – 5/2015 Hematologist in the clinic for Hematology and Oncology of Marienhospital, Düsseldorf, Germany
• 10/2015 – 5/2018 Hematologist, 1st Propedeutic Clinic for Internal Medicine, Laikon General Hospital, Athens, Greece
• 6/2018 – 7/2022 Hematologist in “Metaxa” hospital in Piraeus
• Since 8/2022 Hematologist in Metropolitan Hospital

MEMBERSHIP IN SOCIETIES & EDITORIAL BOARDS

• Member of Medical Association of Piraeus
• Member of Hellenic Hematology Association
• Member of European Hematology Association
• Reviewer for the scientific Magazine “Case reports in Hematology”

RESEARCH PROGRAMS

• Subinvestigator in MiraCLLe Study: An Epidemiological, Prospective, two-year cohort study to Record the True First- and Second-Line Treatment Strategy, in Daily Clinical Practice, Metropolitan Hospital

DISTINCTIONS & AWARDS

• “Young Investigator Award” for the following oral presentation in the Sixth International Workshop on Waldenstrom’s Macroglobulinemia, October 6 – 10 2010, Venice, Italy.
  Clinical impact of increased serum free light chains (sFLCs) or their ratio (FLCR) on WM at diagnosis and during disease course.
  D. Maltezas, T. Tzenou, N. Kafassi, E. Koulieris, V. Bartzis, M. Dimou, A. Efthymiou, G. Georgiou, T.P. Vassilakopoulos, M.K. Angelopoulou, P. Tsaftaridis, P. Panayiotidis, P. Beris, M-C Kyrtsonis.
  Quantification of serum IgM kappa and IgM lambda in patients with Waldenstrom’s Macroglobulinemia.
  E. Koulieris, M-C Kyrtsonis, D. Maltezas, T. Tzenou, L. Mirbahai, G. Mead, P. Panayiotidis, A.R. Bradwell, S. Harding.
• Award for best Poster in its category. 7TH International Symposium on Clinical Applications of FLC & HLC, Edinburgh, UK, 16-17/6/15 για την εργασία:
  Serum free light chain (FLC) and soluble syndecan-1 levels are major markers of disease evolution of smoldering multiple myeloma (SMM) patients.
  Nikolaou E, Maltezas D, Koulieris E, Iliakis T, Viniou NA, Kotsanti S, Bitsani A, Bartzis V, Tzenou T, Dimou M, Panayiotidis P, Kyrtsonis MC.
  Hematology Reports 2015; 7(s1), pp28

PUBLICATIONS

• Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
  Maltezas D, Dimopoulos MA, Katodritou I, Repousis P, Pouli A, Terpos E, P, Delimpasi S, Michalis E, Anargyrou K,Gavriatopoulou M, Stefanoudaki A, Tzenou T, Koulieris E, Sachanas S, Dimou M, Vassilakopoulos TP, Angelopoulou MK, Pangalis GA, MC. Hematol Oncol. 2012
• Prognostic significance of serum free light chains in Chronic Lymphocytic Leukemia
  K. Sarris, D. Maltezas, E. Koulieris, V. Bartzis, T. Tzenou, S. Sachanas, E. Nikolaou, A. Efthymiou, K. Bitsani, M. Dimou, T. Vassilakopoulos, M. Siakantaris, M. Angelopoulou, F. Kontopidou, P. Tsaftaridis, N. Kafasi, G. Pangalis, P. Panayiotidis, S. Harding, M-C. Kyrtsonis.
  Adv Hematol. 2013;2013:359071
• Contribution of new immunoglobulin-derived biomarkers in plasma cell dyscrasias and lymphoproliferative disorders.
  Kyrtsonis MC, Maltezas D, Koulieris E, Tzenou T, Harding SJ.
  WorldJHematol 2013; 2(2): 6-12
• The contribution of prognostic factors to the better management of multiple myeloma patients.
  M-C Kyrtsonis, D Maltezas, E Koulieris, Catherine Bitsanis, Ilias Pessach, Anna Efthymiou, Vassiliki Bartzis, Tatiana Tzenou, Panayiotis Panayiotidis.
  Multiple Myeloma An Overview Chapter 8: Pages 145-174
• Response to bortezomib in refractory/relapsed multiple myeloma patients: a single center experience with discussion on specific issues.
  M-C. Kyrtsonis, D. Maltezas, E. Koulieris, C. Zaroulis, T. Tzenou, S. Sachanas, V. Bartzis, G. Georgiou, M. Dimou, S. Siakavellas, T.P. Vassilakopoulos, M.K. Angelopoulou, E. Koutra, A. Mouzaki, G.A. Pangalis, P. Panayiotidis.
  The Asia-Pacific Journal of Oncology & Hematology 2010; Vol 1, Issue 4
• Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma.
  M-C. Kyrtsonis, D. Maltezas, T. Tzenou, E. Koulieris, A.R. Bradwell.
  Seminars in Hematology. 2009 (2):110-7
• Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course.
  Nikolaou E, Koulieris E, Maltezas D, Sarris A, Iliakis T, Vyniou N.A, Vardounioti I, Κarali V, Pessah I, Efthymiou A, Bitsani A, Bartzis V, Tzenou T, Dimou M, Vassilakopoulos TP, Angelopoulou ΜΚ, Tsaftaridis P, Tsalimalma K, Κafasi Ν, Panayiotidis P, Kyrtsonis M-C.
  CurrentCancerTherapyReviews, 2014, 10.2: 90-96
• Biology and treatment of skeletal manifestations in multiple myeloma
  Stavropoulos N, Papadoyiannis A, Maltezas D, Stavrou P, Pangalis GA, Papagelopoulos PJ, Kyrtsonis MC.
  Journal of Cancer Therapy, 2014, 5, 387-402.
• Prognostic contribution of new immunoglobulin biomarkers (Freelite, Hevylite) in Waldenstrom’s Macroglobulinemia (WM).
  MC Kyrtsonis, E. Koulieris, D. Maltezas, T. Tzenou, S. Harding, E. Kastritis, N. Kafassi, V. Bartzi, A. Efthymiou, K. Bitsanis, M. Gavriatopoulou, E. Terpos, C. Kalpadakis, M K Angelopoulou, T. P. Vassilakopoulos, AR Bradwell, PH. Berris, GA Pangalis, P. Panayiotidis, MA Dimopoulos
  American Journal of Medicine and Medical Science 2012; 2(6): 136-143
• Novel m-component based biomarkers in Waldenström’s Macroglobulinemia.
  Leleu X, Koulieris E, Maltezas D, Itzykson R, Xie W, Manier S, Dulery R, Boyle E, Gauthier J, Poulain S, Tatiana T, Panayiotidis P, Bradwell AR, Harding S, Leblond V, Kyrtsonis MC, Ghobrial IM Clin Lymphoma Myeloma Leuk. 2011;11(1):164-7

CONTACT INFO

+30 210 4809471

EDUCATION & ACADEMIC TITLES

Medical Degree, School of Medicine, National and Kapodistrian University of Athens

PhD, School of Medicine, National and Kapodistrian University of Athens

MSc, National and Kapodistrian University of Athens

Pediatric Specialty, 2nd Department of Academic Pediatrics, University of Athens, General Children's Hospital of Athens "Panagiotis & Aglaia Kyriakou"

Certificate in Atherosclerosis and Related Diseases of Hellenic Society of Atherosclerosis

PROFESSIONAL EXPERIENCE

Deputy Director of Pediatric Clinic, MITERA Children’s Hospital

Αcademic associate in metabolic disorders, 2nd Department of Academic Pediatrics, University of Athens

Consultan Pediatrician, 2nd Department of Academic Pediatrics, University of Athens, General Children's Hospital of Athens "Panagiotis & Aglaia Kyriakou"

Scientific associate in Lipid Disorders Outpatient Department, 2nd Department of Academic Pediatrics, University of Athens, General Children's Hospital of Athens "Panagiotis & Aglaia Kyriakou"

MEMBERSHIP IN SOCIETIES

Member of Hellenic Society for the study of Endogenous Metabolic Diseases

Μember of Hellenic and European Atherosclerosis Society

PUBLICATIONS

1. Papadaki M, Marmarinos A, Tsolia M, Gourgiotis D, Soldatou Α. Cathelecidin levels in nasal secretions are associated with the severity of acute bronchiolitis. Ped Pulm. 2021. doi: https://doi.org/10.1002/ppul.25349
2. Karapostolakis G, Vakaki M, Attilakos A, Marmarinos A, Papadaki M, Koumanidou C, Alexopoulou E, Gourgiotis D, Garoufi A. The effect of Long-Term Atorvastatin Therapy on Carotid Intima- Media Thickness of Children with Dyslipidemia. Angiology. 2020; 72(4):322-331.
   doi: 10.1177/0003319720975635.
3. Garoufi A, Pagoni A, Papadaki M, Marmarinos A, Karapostolakis G, Michala L, Soldatou A. Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index. Children (Ba-sel). 2021 Dec 22;9(1):4. doi: 10.3390/children9010004.
4. Garoufi A, Koumparelou A, Askiti V, Lykoudis P, Mitsioni A, Drapanioti S, Servos G, Papadaki M, Gourgiotis D, Marmarinos A. Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study. Children (Basel). 2022 Jun 19;9(6):916. doi: 10.3390/children9060916
5. Karaviti D, Charakida M, Dimopoulou D, Eleftheriou E, Liaska M, Papadaki M, Maritsi D, Sakou I, Marmarinos A, Avgeris M, Gourgiotis D, Spyridis N, Tsolia M. Long term cardiovascular effects of COVID-19 infection in children. JACC, 2023 Mar, 81(8):1555.
6. Fotis L, Papadaki M, Tsiribis V, Varanaki ME, Tzanavaris P, Tsolas G. Multisystem Inflammatory Syndrome in children related to COVID-19. Report of two cases. Pediatriki, Vol 84(3), 2021.

SCIENTIFIC POSTERS AND ORAL PRESENTATIONS

1. Attilakos A., Zerva O., Papadaki M., Stamati A., Parasxou N., Loizou K., Garoufi A. Effect of phytosterols on serum lipids of children with hypercholesterolemia. Annual Symposium of the Society for the study of Inborn Errors of Metabolism 2018, O-020.
2. Attilakos A., Garoufi A., Pergantou E., Gyftodimou E., Katramis A., Papadaki M., Papadakis M., Maroulis V., Paramera E. Sitosterolemia in a 9-year old girl pre-senting initially as severe hypercholesterolemia. Annual Symposium of the Soci-ety for the study of Inborn Errors of Metabolism 2018, E-177.
3. A. Attilakos, A. Theodorakopoulos , D. Polymeros , M. Papadaki , A. Nagra, M. Goutaki, A. Garoufi, A. Prasouli, A. Kourti, S. Fessatou. Ready Steady Go transi-tion program for Greek adolescents with inflammatory bowel and celiac dis-ease, AS-UEG-2021-02059, P 1117.
4. Papadaki M, Garoufi A, Papanikolaou Z, Michelakai E, Dimitriou E, Kossyva L. Infant with coarse facial features, hepatosplenomegaly and anemia: GM1 gangliosidosis. 53rd Panhellenic Paediatric Congress 2015, AA052, Thessaloniki
5. Karapostolakis G, Attilakos A, Vakaki M, Marmarinos A, Papadaki M, Koumanidou C, Alexopoulou E, Gourgiotis D, Garoufi A. The effect of Long-Term Atorvastatin Therapy on Carotid Intima- Media Thickness of Children with Dyslipidemia, 8th Panhellenic Congress of the Working Groups of the Hellenic Atherosclerosis Society 2019, HAA10.
6. Garoufi A, Koniari E, Papakonstantinou E, Papadaki M, Papadakis E, Kalogiannis M, Zerva O, Pergantou E, Attilakos A. Phytosterolemia in children: When to suspect? 10th Panhellenic Congress of the Working Groups of the Hellenic Atherosclerosis Society 2023, HAA08.

AUTHORSHIP

Participation in writing "Developments in Pediatric Diagnostics and Therapeutics" of the 35th Postgraduate Seminar 2nd Department of Academic Pediatrics, University of Athens, 2015.

Participation in writing "Cardiological algorithms in pediatric practice" Tutorial manual, 2nd Department of Academic Pediatrics, University of Athens & Department of Cardiology, General Children's Hospital of Athens "Panagiotis & Aglaia Kyriakou", 2021

CONTACT INFO

Τηλέφωνο: 2104809007

EDUCATION & ACADEMIC TITLES

07/23/2002 MEDICAL DEGREE. UNIVERSITY OF L'AQUILA, ITALlA

24/07/2014 DOCTOR OF THE UNIVERSITY OF ATHENS-PhD

11/2011 - 12/2012 and 08/2013-07/2014 Education at the Diabetes Center of the 2nd Internal Medicine Department 'Attikon' University Hospital

03/2020 Holder of a specialization title in Diabetes Mellitus after successful examinations of the Ministry of Health

PROFESSIONAL EXPERIENCE

06/2019 - 06/2024 Associate Director of the 1st Department of Internal Medicine and Diabetes Center of 'Henry Dunant' Hospital Center.

05/2015 - 05/2019 Consultant of the 1st Department of Internal Medicine and Diabetes Center of 'Henry Dunant' Hospital Center.

Since 10/ 2015 Private Clinic in Nea Smyrni.

10/2014 - 04/2015 External partner of the 'Henry Dunant' Hospital Center.

08/2013 - 07/2014 Consultant at the Emergency Department, Attikon University Hospital, Athens.

06/2013 - 07/2013 MD – Diabetes Specialist, Queens Hospital, Burton on Trent-England.

01/2013 - 05/2013 MD – Diabetes Specialist, Blackpool Teaching Hospital, Blackpool-England.

27/04/2007 to 09/04/2012 Trainee of the 2nd Internal Medicine Department 'Attikon' University Hospital (Full specialization

12/2005 - 12/2006 Internship at the Larnaca General Hospital (6 months in the Pathology Clinic and 6 months in the Surgery Clinic)

10/2003 - 01/2005 MD- Compulsory Field Service at the Regional Clinic of Kastelani Messi - Corfu (K.Y Agios Athanasios)

10/2002 - 04/2003 Compulsory Internship at the University Hospital of L'Aquila

MEMBERSHIP IN SOCIETIES

1. Hellenic Diabetes Association
2. Hellenic Society of Internal Medicine
3. Professional Association of Internist- Diabetologist of Greece

PEER REVIEWER AT SCIENCE JOURNAL

1. Biocatalysis and Agricultural Biotechnology
2. Nutrition Reviews
3. The British Journal of Nutrition 
4. International Journal of Food Science and Technology
5. International Journal of Environmental Research and Public Health

AWARDS

Awards from the Hellenic Diabetes Association due to Paper Posts at the European Congress of Diabetes Mellitus (E.A.S.D 2014 Vienna. Austria and EASD 2015 Stockholm, Sweden)

PUBLICATIONS AT INTERNATIONAL JOURNALS

1. Vinegar decreases postprandial hyperglycemia in patients with type 1 diabetes Mitrou P, Raptis A, Lampadiari V, Boutati E, Petsiou E, Spanoudi F, Papakostantinou E, Maratou E, Econompopoulos T, Dimitriadis G, Raptis SA. Diabetes Care. 2010 Feb;33(2):e27
2. Vinegar’s action on glucose metabolism, lipid profile and body weight: Efficacy and underlying mechanisms E. Petsiou, P. Mitrou, S. A. Raptis and G. Dimitriadis. Nutrition Reviews. 2014 Oct;77 (10);651-661
3. The role of acetic acid on glucose uptake and blood flow rates in the skeletal muscle in humans with impaired glucose tolerance P. Mitrou, E. Petsiou, E. Papakonstantinou, E. Maratou, V. Lambadiari, P. Dimitriadis, F. Spanoudi, S. A. Raptis and G. Dimitriadis. Eur J Clin Nutr. 2015 Jan 28
4. Vinegar Consumption Increases Insulin-Stimulated Glucose Uptake by the Forearm Muscle in Humans with Type 2 Diabetes P. Mitrou, E. Petsiou, E. Papakonstantinou, E. Maratou, V. Lambadiari, P. Dimitriadis, F. Spanoudi, S. A. Raptis and G. Dimitriadis J Diabetes Res. 2015
5. Greek internists’ and endocrinologists’ knowledge, attitudes and behaviors regarding periodontal disease, caries, xerostomia and diabetes mellitus. A National Survey. C. Rahiotis, E. Petsiou, P. Mitrou Int J Biomed Clin Anal.2022;2(1):39-47
6. Two-Month Consumption of Orange Juice Enriched with Vitamin D3 and Probiotics Decreases Body Weight, Ιnsulin Resistance, Blood Lipids, and Arterial Blood Pressure in High-Cardiometabolic-Risk Patients on a Westernized Type Diet:Results from a Randomized Clinical Trial.E. Papakonstantinou , N. Zacharodimos, G. Georgiopoulos, C. Athanasaki, D. Bothou, S. Tsitsou, F. Lympaki, S. Vitsou-Anastasiou, O. Papadopoulou, D. Delialis, E. Alexopoulos, E. Petsiou, K. Keramida, A. Doulgeraki, Ι. Patsopoulou, G. Nychas, C. Tassou. Nutri-ents 2024, 16(9), 1331
7. Effects of a hypocaloric time- restricted feeding diet programme in individuals with metabolic dysfunction- associated steatotic liver disease: preliminary data of a randomised contolled trial S. Tsitsou, T.Bali, M. Adamantou, A. Sarilaki, K-A. Poulia, E. Petsiou, E. Papakonstantinou, E. Cholongitas. Diabetologia 09/2024. Abstract 26